Skip to main content
. 2023 Jan 6;13:1068421. doi: 10.3389/fpsyg.2022.1068421

Table 1.

Characteristics of the study group.

Variable Values
Age [years], mean ± SD 36.23 ± 11.77
Sex, n (%)
Female 82 (82)
Male 18 (18)
Education, n (%)
Basic or vocational education 21 (21)
Secondary education 42 (42)
Higher education 37 (37)
Place of residence, n (%)
Village 20 (20)
City 80 (80)
Marital status, n (%)
Single 38 (38)
Married 41 (49)
Widowed 2 (2)
Divorced 11 (11)
Material status, n (%)
0–500 PLN 9 (9)
501–1,000 PLN 28 (28)
1,001–2000 PLN 35 (35)
> 2000 PLN 28 (28)
Clinical type of MS, n (%)
RRMS 77 (77)
SPMS 13 (13)
PPMS 4 (4)
PRMS 6 (6)
Disease duration, n (%)
0–5 years 44 (44)
6–10 years 21 (21)
> 10 years 35 (35)
Using DMT, n (%)
Yes 28 (28)
No 72 (72)
EDSS, mean ± SD (min–max) 3.13 ± 2.38 (0–10)
ADL (points), n (%)
0–2 14 (14)
3–4 14 (14)
5–6 72 (72)
IADL, mean ± SD (min–max) 21.54 ± 3.06 (8–24)
BDI (points), n (%)
0–11 32 (32)
12–26 46 (46)
27–49 18 (18)
50–63 4 (4)
Complains, n (%)
Mobility and balance disorders 66 (66)
Sphincter disorders 49 (49)
Dysphagia 3 (3)
Fatigability 81 (81)
Vision disorders 43 (43)
Hypertonia 47 (47)
Sensory disorders 34 (34)
Speech disorders 14 (14)
Sexual disorders 40 (40)
Mood disorders 26 (26)
Cognitive impairment 30 (30)

RRSM, relapsing–remitting MS; SPMS, secondary progressive MS; PPMS, primary progressive MS; PRMS, progressive-relapsing MS; DMT, disease-modifying therapy; EDSS, Expanded Disability Status Scale; ADL, Activities of Daily Living questionnaire; IADL, Instrumental Activities of Daily Living questionnaire; BDI, Beck Depression Inventory.